FIBROGEN, INC.

FGEN
Real-time Estimate Quote. Real-time Estimate  - 11/25 11:57:49 am
40.635USD -1.68%
Prev.41.3300
Open41.3300
High41.4000
Low40.7200
Volume38 913
Latest news
11/12
11/09
11/06
11/06
Chart FIBROGEN, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralBullish
Resistance45,649,048,8
Spread/Res.-11%-17%-17%
Spread/Supp.6,2%25%16%
Support38,432,635,0
Financials
Sales 2020 231 M - -
Net income 2020 -147 M - -
Net Debt 2020 - - -
P/E ratio 2020 -26,2x
Yield 2020 -
Capitalization 3 761 M 3 761 M -
Capi. / Sales 2020 16,3x
Capi. / Sales 2021 7,67x
Nbr of Employees 531
Free-Float 91,7%
Company
FibroGen, Inc. is a biopharmaceutical company committed to discovering, developing and commercializing a pipeline of first-in-class therapeutics. The Company applies its capabilities in hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF) biology to advance innovative medicines...

>> Read more
Sector :
Biotechnology & Medical Research - NEC
Calendar :
2021-03-03 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 62,13 $
Last Close Price 41,33 $
Spread / Highest target 123%
Spread / Average Target 50,3%
Spread / Lowest Target 6,46%